BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31801714)

  • 21. LZTS2 inhibits PI3K/AKT activation and radioresistance in nasopharyngeal carcinoma by interacting with p85.
    Xu S; Li Y; Lu Y; Huang J; Ren J; Zhang S; Yin Z; Huang K; Wu G; Yang K
    Cancer Lett; 2018 Apr; 420():38-48. PubMed ID: 29409973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
    Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of miR-155 promotes apoptosis of nasopharyngeal carcinoma CNE-1 cells by targeting PI3K/AKT-FOXO3a signaling.
    Wu S; Xie DL; Dai XY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7391-7398. PubMed ID: 31539126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide analysis of long non-coding RNA in primary nasopharyngeal carcinoma by microarray.
    Yang QQ; Deng YF
    Histopathology; 2015 Jun; 66(7):1022-30. PubMed ID: 25406670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
    Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
    Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 30. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase 1 promotes tumorigenesis and inhibits the sensitivity to 5-fluorouracil of nasopharyngeal carcinoma.
    Song L; Liu H; Liu Q
    Biomed Pharmacother; 2019 Oct; 118():109120. PubMed ID: 31302419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway.
    Zhao Q; Sun P; Qin S; Liu J
    Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated NF-κB signal promotes the hub gene PCLAF expression to facilitate nasopharyngeal carcinoma proliferation and metastasis.
    Ma F; Zhi C; Wang M; Li T; Khan SA; Ma Z; Jing Z; Bo C; Zhou Q; Xia S; Huang S; Huang S; Zhang Z; Jia H; Cui X; Yao M; Ji T
    Biomed Pharmacother; 2020 May; 125():109905. PubMed ID: 32070873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma.
    Zhao S; Zhang Y; Liang X; Li M; Peng F; Chen Z; Chen Y
    Anticancer Agents Med Chem; 2019; 19(6):772-782. PubMed ID: 30714531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
    Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
    Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
    [No Abstract]   [Full Text] [Related]  

  • 37. An actin-WHAMM interaction linking SETD2 and autophagy.
    Seervai RNH; Grimm SL; Jangid RK; Tripathi DN; Coarfa C; Walker CL
    Biochem Biophys Res Commun; 2021 Jun; 558():202-208. PubMed ID: 33036756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of exosomes from nasopharyngeal carcinoma cell identifies intercellular transfer of angiogenic proteins.
    Chan YK; Zhang H; Liu P; Tsao SW; Lung ML; Mak NK; Ngok-Shun Wong R; Ying-Kit Yue P
    Int J Cancer; 2015 Oct; 137(8):1830-41. PubMed ID: 25857718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling.
    Jiang C; He C; Wu Z; Li F; Xiao J
    Biochem Biophys Res Commun; 2018 Jul; 502(3):382-388. PubMed ID: 29842882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human serum protein targets of Qianggu Decoction () in primary type I osteoporosis based on tandem mass tag labeling and liquid chromatography-tandem mass spectrometry technology.
    Liang BC; Shi XL; Li CW; Shi ZY; He WT; Yao JL; Kong LC; Li XY
    Chin J Integr Med; 2017 Oct; 23(10):747-754. PubMed ID: 27389089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.